-
FDA finds sterilization issues at eye drop plant
The FDA found sterilizations issues at a Global Pharma facility, which manufactured eye drops contaminated with Pseudomonas aeruginosa, CNN reported April 3. -
Emerge Manufacturing breaks ground on 50K-square-foot facility
Emerge Manufacturing, a Cincinnati-based hospital manufacturing company, will break ground on its 50,000-square-foot, personal protective equipment manufacturing plant April 4. -
FTC orders Illumina to divest cancer test maker
The Federal Trade Commission on April 3 ordered Illumina to divest cancer test maker Grail, saying the $7.1 billion deal would substantially stifle competition for cancer diagnostics in the U.S. -
FDA probes unapproved devices that widen jaws
The FDA is evaluating safety concerns with unapproved dental devices after receiving "reports of serious complications," the agency said March 30. -
Medline opens $72M distribution center in Louisiana
On March 30, Medline opened its 650,000-square-foot distribution center in Hammond, La., after investing $72 million into the facility, according to a news release shared with Becker's. -
'How do you help nurses?' and other priorities from Mount Sinai's chief supply chain officer
For Carlos Maceda, chief supply chain officer for Mount Sinai Health System in New York City, mentoring the next generation of supply chain leaders is a top priority. -
Medline signs deal with national GPO to provide supplies to public health sites, schools
Medical supply company Medline made a distribution agreement with a national purchasing organization to provide its products to up to 26,000 state agencies, counties, cities and school districts, Medline said March 28. -
FDA finalizes PHE transition plan for medical devices
With the COVID-19 public health emergency set to expire May 11, the FDA is preparing to prevent any supply disruptions to medical devices after three years of shortages partly spurred by the pandemic. -
6 recent FDA recalls, warnings, approvals
Here are six FDA recalls, approvals and warnings Becker's has covered since Feb. 24: -
FDA clears thinner nitrile gloves made by Ochsner's supply company
The FDA greenlit SafeSource Direct's new nitrile exam gloves that are designed to weigh less "to offer a cost-effective solution" for "low-risk, high-volume environments," the company said March 21. -
FDA recalls 2K Datascope heart balloon pumps
More than 2,000 heart balloon pumps are part of a Class I recall issued by the FDA. -
Hospital supplies disrupted by COVID-19 will soon replenish, FDA says
The FDA revised its list of medical device shortages spurred by the COVID-19 pandemic on March 16 to update more than a dozen products returning to normal supply levels in 2023. -
FDA issues third warning letter to Olympus Medical over faulty endoscopes
The FDA issued a third warning letter to Olympus Medical, which manufactures endoscopes, following an inspection and 160 complaints of faulty equipment. -
Top 50 health system, hospital supply chains
The Global Healthcare Exchange revealed March 14 its list of the top 50 supply chains among hospitals and health systems. -
More hospitals want to bring supply chain in-house: Survey
About half of the nation's hospitals are eyeing more control of the medical supply chain, according to a survey sample involving 250 hospital and health system leaders. -
FDA trims umbrella EUA for surgical masks used in healthcare
The FDA narrowed its umbrella emergency use authorization for disposable, single-use surgical masks used in healthcare on March 6 after more than two years of the EUA prompted by the COVID-19 pandemic. -
The power of optimization: Supply chain strategies hospitals can't afford to ignore in 2023
During the pandemic, product disruptions were the norm for healthcare supply chain teams. Many organizations didn't have the analytics or technologies necessary to analyze problems and develop solutions. Today, supply chain leaders at hospitals and health systems face additional challenges due to talent shortages and rampant inflation. -
Mass General Brigham switches supply vendors
Boston-based Mass General Brigham tapped Medline on Feb. 27 as its strategic medical supply vendor. -
10 months later, GE's contrast dye nears normal supply levels
GE Healthcare said Feb. 23 it expects its contrast media products, which are used in CT scans and fell into shortage in May 2022, will return to normal supply levels in the next few weeks. -
FDA warns of infant incubators with possible airborne chemical risk
Neonatal incubators may be exposing people to "volatile chemicals," the FDA warned healthcare workers Feb. 23.
Page 26 of 50